Literature DB >> 3056934

Enhancement of inositol phospholipid metabolism and activation of protein kinase C in ras-transformed rat fibroblasts.

M Huang1, K Chida, N Kamata, K Nose, M Kato, Y Homma, T Takenawa, T Kuroki.   

Abstract

The inositol phospholipid metabolism is one of the main pathways of signal transduction in cells. We measured the activities of its key enzymes in v-Ha-ras-transformed 208F rat fibroblasts. In the ras-transformed clones, incorporation of [32P]Pi into intermediates of the inositol phospholipid metabolism was stimulated. The activities of phosphatidylinositol and phosphatidylinositol-4-phosphate kinases in the transformed clones were about 35-50% more than in untransformed cells, indicating increased inositol phospholipid metabolism. However, the activity of diacylglycerol kinase in their membrane fraction was 25-35% less than that of untransformed cells, although the total diacylglycerol kinase activity did not change. The imbalance of these kinases could constitute one of the main reasons leading to the increased level of inositol phosphates and the accumulation of diacylglycerol to 2-2.2 times that in control 208F cells. Phosphatidylinositol-4,5-bisphosphate-phospholipase C activity did not change on the transformation when assayed under various conditions. The increased level of diacylglycerol caused intracellular translocation, activation, and down-regulation of protein kinase C changes which may be one of the essential events in transformation by the v-Ha-ras gene.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3056934

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  Differential pathways (phospholipase C and phospholipase D) of bradykinin-induced biphasic 1,2-diacylglycerol formation in non-transformed and K-ras-transformed NIH-3T3 fibroblasts. Involvement of intracellular Ca2+ oscillations in phosphatidylcholine breakdown.

Authors:  T Fu; Y Okano; Y Nozawa
Journal:  Biochem J       Date:  1992-04-15       Impact factor: 3.857

Review 2.  The biochemistry of ras p21.

Authors:  R J Grand; D Owen
Journal:  Biochem J       Date:  1991-11-01       Impact factor: 3.857

3.  NIH-3T3 cells transformed with a ras oncogene exhibit a protein kinase C-mediated inhibition of agonist-stimulated Ca2+ inflow.

Authors:  A J Polverino; B P Hughes; G J Barritt
Journal:  Biochem J       Date:  1990-10-15       Impact factor: 3.857

4.  Lithium administration to preadolescent rats causes long-lasting increases in anxiety-like behavior and has molecular consequences.

Authors:  Rachael M Youngs; Melissa S Chu; Edward G Meloni; Alipi Naydenov; William A Carlezon; Christine Konradi
Journal:  J Neurosci       Date:  2006-05-31       Impact factor: 6.167

Review 5.  Oncogene-directed alterations in cancer cell metabolism.

Authors:  Arvindhan Nagarajan; Parmanand Malvi; Narendra Wajapeyee
Journal:  Trends Cancer       Date:  2016-06-27

6.  Protein kinase C isoform alpha overexpression in C6 glioma cells and its role in cell proliferation.

Authors:  G H Baltuch; N P Dooley; K M Rostworowski; J G Villemure; V W Yong
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

Review 7.  Ras oncogenes: split personalities.

Authors:  Antoine E Karnoub; Robert A Weinberg
Journal:  Nat Rev Mol Cell Biol       Date:  2008-07       Impact factor: 94.444

8.  Spontaneously oscillating K+ channel activity in transformed Madin-Darby canine kidney cells.

Authors:  A Schwab; H J Westphale; L Wojnowski; S Wünsch; H Oberleithner
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

9.  Novel revertants of H-ras oncogene-transformed R6-PKC3 cells.

Authors:  R S Krauss; S N Guadagno; I B Weinstein
Journal:  Mol Cell Biol       Date:  1992-07       Impact factor: 4.272

10.  Oncogenicity of AKR mink cell focus-inducing murine leukemia virus correlates with induction of chronic phosphatidylinositol signal transduction.

Authors:  A M al-Salameh; M W Cloyd
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.